We are live on
!
Find out more
CC
Callan Capital Portfolio holdings
AUM
$1.35B
Turnover
17.35%
1-Year Est. Return
8.35%
This Fund
S&P 500
This Quarter
Est. Return
+11.93%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$470M
AUM Growth
+$29.3M
(+6.7%)
Cap. Flow
-$17.8M
Cap. Flow
% of AUM
-3.78%
Top 10 Holdings %
Top 10 Hldgs %
73.69%
Holding
76
New
3
Increased
26
Reduced
21
Closed
8
Avg Time Held
1.2
years
Top 10 Avg Time Held
1.4
years
Top 20 Avg Time Held
1.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust Global Tactical Commodity Strategy Fund
FTGC
|
+$4.72M |
| 2 |
Vanguard FTSE Europe ETF
VGK
|
+$4.01M |
| 3 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
+$3.34M |
| 4 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$2.89M |
| 5 |
Invesco DB Commodity Index Tracking Fund
DBC
|
+$916K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShare MSCI Eurozone ETF
EZU
|
+$2.93M |
| 2 |
CFN
CAREFUSION CORPORATION
CFN
|
+$2.24M |
| 3 |
Halozyme
HALO
|
+$1.94M |
| 4 |
Regulus Therapeutics
RGLS
|
+$1.28M |
| 5 |
Alerian MLP ETF
AMLP
|
+$1.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 97.16% |
| 2 | Healthcare | 1.75% |
| 3 | Real Estate | 0.45% |
| 4 | Consumer Staples | 0.2% |
| 5 | Materials | 0.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
MBFI
51
DELISTED
MB Financial Corp
MBFI
| $492K | 0.1% |
15,705
| – | – |
2014 Q2
3 quarters
|
|
52
Becton Dickinson
BDX
$52.8B
| $420K | 0.09% |
+3,000
| New | +$420K |
2015 Q1
0 quarters
|
|
53
Apple
AAPL
$4.99T
| $377K | 0.08% |
12,124
-7,220
| -37% | -$218K |
2014 Q2
3 quarters
|
|
54
State Street SPDR S&P 500 ETF Trust
SPY
$815B
| $368K | 0.08% |
1,784
-176
| -9% | -$36.3K |
2014 Q3
2 quarters
|
|
55
Acadia Pharmaceuticals
ACAD
$3.4B
| $326K | 0.07% |
10,000
| – | – |
2014 Q3
2 quarters
|
|
56
Vanguard Energy ETF
VDE
$11.2B
| $320K | 0.07% |
2,930
| – | – |
2014 Q4
1 quarter
|
|
57
Illumina
ILMN
$40.5B
| $296K | 0.06% |
1,637
| – | – |
2014 Q1
4 quarters
|
|
58
WisdomTree US LargeCap Dividend Fund
DLN
$6.31B
| $276K | 0.06% |
7,520
| – | – |
2013 Q2
7 quarters
|
|
59
Sempra
SRE
$53.6B
| $265K | 0.06% |
4,860
+1,164
| +31% | +$64.1K |
2014 Q4
1 quarter
|
|
60
Tesla
TSLA
$1.43T
| $254K | 0.05% |
20,145
| – | – |
2014 Q2
3 quarters
|
|
61
iShares MSCI EAFE ETF
EFA
$76.9B
| $236K | 0.05% |
3,676
+11
| +0.3% | +$693 |
2014 Q4
1 quarter
|
|
62
DELISTED
Assertio
ASRT
| $224K | 0.05% |
167
| – | – |
2014 Q2
3 quarters
|
|
63
iShares Core S&P 500 ETF
IVV
$889B
| $212K | 0.05% |
1,020
| – | – |
2014 Q3
2 quarters
|
|
|
IMUC
64
DELISTED
ImmunoCellular Therapeutics, Ltd.
IMUC
| $157K | 0.03% |
8,098
-1,750
| -18% | -$43.9K |
2013 Q2
7 quarters
|
|
65
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| – | – |
0
| – | – |
2014 Q2
3 quarters
|
|
|
BIOC
66
DELISTED
Biocept, Inc.
BIOC
| $38K | 0.01% |
+1
| New | +$67.2K |
2015 Q1
0 quarters
|
|
67
DELISTED
Hepion Pharmaceuticals
HEPA
| – | – |
0
| – | – |
2015 Q1
0 quarters
|
|
|
68
Alerian MLP ETF
AMLP
$12.5B
| – | – |
-13,772
| Closed | -$1.21M | – |
|
|
69
iShare MSCI Eurozone ETF
EZU
$9.26B
| – | – |
-80,620
| Closed | -$2.93M | – |
|
70
Gilead Sciences
GILD
$195B
| – | – |
-2,948
| Closed | -$278K | – |
|
|
71
DELISTED
Regulus Therapeutics
RGLS
| – | – |
-667
| Closed | -$1.28M | – |
|
|
CUDA
72
DELISTED
Barracuda Networks, Inc.
CUDA
| – | – |
-13,750
| Closed | -$493K | – |
|
|
IPCM
73
DELISTED
IPC HEALTHCARE INC COM DTD
IPCM
| – | – |
-8,293
| Closed | -$381K | – |
|
|
CFN
74
DELISTED
CAREFUSION CORPORATION
CFN
| – | – |
-37,677
| Closed | -$2.24M | – |
|
Similar funds
PRO
MBA
SIA
AP
MW
SBIA
LC
TW
Callan Capital's Q1 2015 Portfolio in Review
As of Q1 2015, Callan Capital held 76 positions worth $470M, up 6.7% from $441M the previous quarter. Its ten largest holdings account for 74% of the portfolio.
Callan Capital withdrew a net $17.8M in Q1 2015, closing 8 positions and reducing 21 holdings. Its most notable exit was iShare MSCI Eurozone ETF, an estimated $2.93M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 97% of assets, up from 96% a quarter earlier, followed by Healthcare and Real Estate.
Against the trend, Callan Capital opened a new position in Invesco DB Commodity Index Tracking Fund worth $888K.
- Callan Capital's largest Q1 2015 buy was Invesco DB Commodity Index Tracking Fund: 52,021 shares worth $888K.
- Callan Capital added most to First Trust Global Tactical Commodity Strategy Fund in Q1 2015, an estimated $4.72M increase.
- Callan Capital's biggest Q1 2015 reduction was Halozyme, cutting an estimated $1.94M.
- Callan Capital fully exited iShare MSCI Eurozone ETF in Q1 2015, selling an estimated $2.93M.
- Callan Capital's ten largest holdings make up 74% of its $470M portfolio in Q1 2015.
- Callan Capital opened 3 new positions and closed 8 in Q1 2015.
- Callan Capital's portfolio value rose 6.7% quarter-over-quarter to $470M.
Based on Callan Capital's 13F filing for Q1 2015, filed 11 May 2015.